Inventiva announces the implementation of an At-The-Market program in the United States

NEXT STORY
TriLink BioTechnologies® Extends Global Support of Covid-19 Vaccine Development into APAC Region with the Chula Vaccine Research Center (Chula VRC), Bangkok
PREV STORY
Fate Therapeutics Announces Treatment of First Patient in Landmark Phase 1 Clinical Trial of FT819, the First-ever iPSC-derived CAR T-Cell Therapy
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Inventiva announces the implementation of an At-The-Market program in the United States

NEXT STORY
TriLink BioTechnologies® Extends Global Support of Covid-19 Vaccine Development into APAC Region with the Chula Vaccine Research Center (Chula VRC), Bangkok
PREV STORY
Fate Therapeutics Announces Treatment of First Patient in Landmark Phase 1 Clinical Trial of FT819, the First-ever iPSC-derived CAR T-Cell Therapy
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AzurRx Announces Appointment of Maged Shenouda as Chief Financial Officer

NEW YORK, Sept. 25, 2017 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or ...

author_avatar
NASDAQ Market News

Argos Therapeutics Announces $6,000,000 Secured Convertible Note Financing

DURHAM, N.C., June 16, 2017 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. (Nasdaq:ARGS), an immuno-oncology ...

author_avatar
NASDAQ Market News

INSTI HIV Self Test Earns WHO Prequalification Status for Home Testing

The newly WHO Prequalified INSTI HIV Self Test makes a mark as it expands ...

author_avatar
NASDAQ Market News